Given that the 14 sites did not use procalcitonin in routine care before the trial began, I'm curious if any of the sites have since picked procalcitonin up as a routinely available lab? Or if any had it become routinely available during the trial?
The discussion briefly touched on how the site difference could have contributed to the discrepancy between ProACT and previous trials of procalcitonin-guided antibiotic prescription. I'm curious if the results would be different at a site(s) that already routinely uses procalcitonin, and if adherence would be higher, especially in the <0.1 procalcitonin group.
Huge thanks to everyone involved in this Journal Club. Very exciting.
Easy one-click social registrationIs this safe?
We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.ORRegister via email
Send me updates on this Contest
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.